Combination Gefitinib and Methotrexate Compared With Methotrexate Alone to Treat Ectopic Pregnancy

医学 甲氨蝶呤 皮疹 耐受性 异位妊娠 吉非替尼 内科学 胃肠病学 不利影响 腹泻 怀孕 癌症 遗传学 生物 表皮生长因子受体
作者
Monika Skubisz,Andrew W. Horne,Terrance G. Johns,Ulrika W. Nilsson,W. Colin Duncan,Euan M. Wallace,Hilary Critchley,Stephen Tong
出处
期刊:Obstetrics & Gynecology [Lippincott Williams & Wilkins]
卷期号:122 (4): 745-751 被引量:37
标识
DOI:10.1097/aog.0b013e3182a14cfb
摘要

In Brief OBJECTIVE: To determine the safety, tolerability, and efficacy of combination gefitinib and methotrexate to treat ectopic pregnancy. METHODS: We performed a phase I, single-arm (nonrandomized), open-label study. Twelve women with ectopic pregnancies were administered methotrexate (50 mg/m2, intramuscular) and 250 mg oral gefitinib in a dose-escalation protocol: one dose (day 1) n=3; three doses (days 1–3) n=3; seven doses (days 1–7) n=6. Efficacy was examined by comparing human chorionic gonadotrophin (hCG) decline and time to resolution with historic controls administered methotrexate only. RESULTS: Common side effects were transient acneiform rash in 67% (8/12) and diarrhea in 42% (5/12) of participants. There was no clinical or biochemical evidence of serious pulmonary, renal, hepatic, or hematologic toxicity. Of six participants with a pretreatment serum hCG level between 1,000 and 3,000 international units/L, hCG levels declined significantly faster than in the control group. Median serum hCG levels by day 7 after treatment were less than one fifth of levels observed among 71 historic controls treated with methotrexate alone (median [interquartile range] hCG in participants 261 [55–1,445] international units/L compared with controls 1,426 [940–2,573]; P=.008). Median time for the ectopic pregnancies to resolve with combination therapy was 34% shorter compared with methotrexate alone (21 days compared with 32 days; P=.018). CONCLUSION: Combination gefitinib and methotrexate has potential as a treatment for ectopic pregnancy but is commonly associated with minor side effects such as transient rash and diarrhea. The treatment requires validation of safety and efficacy in a larger trial. CLINICAL TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry, www.anzctr.org, AC'TRN12610000684022. LEVEL OF EVIDENCE: II The combination of gefitinib and methotrexate has potential as a treatment for ectopic pregnancy, although minor side effects are common.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
盒盒怪发布了新的文献求助10
刚刚
刚刚
盒盒怪发布了新的文献求助10
刚刚
刚刚
盒盒怪发布了新的文献求助10
刚刚
盒盒怪发布了新的文献求助10
刚刚
盒盒怪发布了新的文献求助10
刚刚
李健的小迷弟应助66HUGE采纳,获得10
1秒前
1秒前
忧心的孤菱完成签到,获得积分10
1秒前
1秒前
mzk完成签到,获得积分10
3秒前
3秒前
盒盒怪发布了新的文献求助10
3秒前
盒盒怪发布了新的文献求助10
4秒前
K先生完成签到,获得积分10
5秒前
乐乐应助瑶我好看采纳,获得10
6秒前
YangyTjjt应助十七采纳,获得10
6秒前
7秒前
7秒前
大象发布了新的文献求助10
7秒前
浮云客完成签到,获得积分10
8秒前
研友_VZG7GZ应助Itazu采纳,获得10
10秒前
Liu完成签到,获得积分10
10秒前
Ishmael给Ishmael的求助进行了留言
11秒前
12秒前
LingC发布了新的文献求助10
12秒前
13秒前
传奇3应助NAZZ采纳,获得10
13秒前
zhaofei完成签到 ,获得积分10
14秒前
渡人舟应助负责的白风采纳,获得10
14秒前
十七发布了新的文献求助10
14秒前
15秒前
大象发布了新的文献求助30
15秒前
17秒前
义气文轩完成签到,获得积分10
18秒前
兔飞发布了新的文献求助10
19秒前
19秒前
20秒前
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Principles of town planning: translating concepts to applications 1000
内視鏡的に摘除しえた十二指腸乳頭部腫瘍の2例 660
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Positive Obsession: The Life and Times of Octavia E. Butler 500
Surgical Ergonomic Pilot Study Using a Posture Biofeedback Device in Rhinology: A MultiPhase Quality Improvement Study 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7692266
求助须知:如何正确求助?哪些是违规求助? 9253447
关于积分的说明 19982887
捐赠科研通 7265074
什么是DOI,文献DOI怎么找? 3291162
关于科研通互助平台的介绍 2447351
邀请新用户注册赠送积分活动 2296377